|
|
||||||||
REVIEW |
INSERM U.418, UMR Communications Cellulaire et Différenciation, Hôpital Debrousse, 29 rue Soeur Bouvier, 69322 Lyon, France
1 INSERM U.545, Institut Pasteur de Lille et Faculté de Pharmacie Université de Lille 2, 1 rue du Pr Calmette, 59019 Lille, France
2 LMCB, Department of Molecular Biomedical Research, V.I.B., Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium
3 Physiologie de la reproduction et des comportements, UMR 6175 INRA-CNRS-Université F. Rabelais de Tours-Haras Nationaux, 37380 Nouzilly, France
(Requests for offprints should be addressed to P Froment; froment{at}lyon.inserm.fr)
Peroxisome proliferator-activated receptors (PPAR
, PPARß/
and PPAR
) are a family of nuclear receptors that are activated by binding of natural ligands, such as polyunsaturated fatty acids or by synthetic ligands. Synthetic molecules of the glitazone family, which bind to PPAR
, are currently used to treat type II diabetes and also to attenuate the secondary clinical symptoms frequently associated with insulin resistance, including polycystic ovary syndrome (PCOS). PPARs are expressed in different compartments of the reproductive system (hypothalamus, pituitary, ovary, uterus and testis). Conservative functions of PPARs in mammalian species could be suggested through several in vivo and in vitro studies, especially in the ovary and during placental development. Several groups have described a strong expression of PPAR
in ovarian granulosa cells, and glitazones modulate granulosa cell proliferation and steroidogenesis in vitro. All these recent data raise new questions about the biologic actions of PPARs in reproduction and their use in therapeutic treatments of fertility troubles such as PCOS or endometriosis. In this review, we first describe the roles of PPARs in different compartments of the reproductive axis (from male and female gametogenesis to parturition), with a focus on PPAR
. Secondly, we discuss the possible molecular mechanisms underlying the effect of glitazones on PCOS. Like other insulin sensitizer molecules, such as metformin, glitazones may in fact act directly on ovarian cells. Finally, we discuss the eventual actions of PPARs as mediators of environmental toxic substances for reproductive function.
This article has been cited by other articles:
![]() |
S. J Holdsworth-Carson, M. Permezel, G. E Rice, and M. Lappas Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor Reproduction, June 1, 2009; 137(6): 1007 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Adibi, R. Hauser, P. L. Williams, R. M. Whyatt, A. M. Calafat, H. Nelson, R. Herrick, and S. H. Swan Maternal Urinary Metabolites of Di-(2-Ethylhexyl) Phthalate in Relation to the Timing of Labor in a US Multicenter Pregnancy Cohort Study Am. J. Epidemiol., April 15, 2009; 169(8): 1015 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M Ocon-Grove, S. M Krzysik-Walker, S. R Maddineni, G. L Hendricks III, and R. Ramachandran Adiponectin and its receptors are expressed in the chicken testis: influence of sexual maturation on testicular ADIPOR1 and ADIPOR2 mRNA abundance Reproduction, November 1, 2008; 136(5): 627 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wathes, D. R. E. Abayasekara, and R. J. Aitken Polyunsaturated Fatty Acids in Male and Female Reproduction Biol Reprod, August 1, 2007; 77(2): 190 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wood, D. A. Dumesic, D. H. Abbott, and J. F. Strauss III Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |